With increasing awareness that a retinal artery occlusion (RAO) is a type of stroke, ophthalmologists must be able to plan the next steps of care when an RAO is identified on exam. Drs. Amanda Henderson and Michael Carper join host Amanda Redfern to guide us through their recommendations and various tricky scenarios, notably whether or not to advise use of tissue plasminogen activator (tPA).

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

How do ChatGPT and other large language models (LLMs) work, and how might ophthalmologists harness their power for use in clinical practice? Drs. Peter Campbell and Travis Redd join host Amanda Redfern to discuss the advent of generative AI and its current and future implications for the practice of ophthalmology.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Dr. Chris Leffler, pediatric ophthalmologist and medical historian, joins host Andrew Pouw to discuss his study of the history of ophthalmology, ranging from the origin and use of the term "glaucoma," to the evolution of cataract surgery from antiquity to the modern era.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Drs. Annie Wishna and Royce Chen join host Jay Sridhar to discuss their experiences teaching trainees with surgical anxiety. Throughout the episode, our guests share their personal anecdotes, measures to overcome surgical anxiety, and how to foster a culture that supports psychological improvement.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Drs. Rupa Wong and Dagny Zhu join host Amanda Redfern to share their experience and expertise using social media to successfully promote their ophthalmic practices and enhance their professional careers.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Drs. Meghan Berkenstock, Stella Kim, and Lauren Dalvin join the show again to teach us about immune checkpoint inhibitors: game changers in oncology, but with a host of ocular side effects. All eye providers will be seeing more patients on this class of medication, and our panel teaches us what to look for and how to manage it.

Additional resources: the National Comprehensive Cancer Network offers a suite of clinical practice guidelines to help clinicians manage immunotherapy ocular adverse events.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Drs. Fasika Woreta and Ekjyot Gill join host Jay Sridhar to discuss the literature and their experiences surrounding socioeconomic determinants of corneal pathology, and how social risk factors impact access to necessary corneal treatment and surgery.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Dr. David Huang joins the show to share his story of developing optical coherence tomography (OCT), for which he, Dr. James Fujimoto, and Eric Swanson won the National Medal of Technology, the highest award for innovators in the United States, as well as the 2023 Lasker–DeBakey Clinical Medical Research Award, often called "America's Nobel Prize."

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.